About NKore Biotherapeutics
NKore Biotherapeutics is a private company based in Germantown, Tennessee, incorporated in 2020 in Delaware. It has reported $250,000 raised in one offering on Form D since April 2023. Its chief executive is R Gregory Brophy.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2023 | Apr 13, 2023 | $250,000of $3.0M target | 2 | $125K | Debt, OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NKore Biotherapeutics's Form D filed Apr 13, 2023.
RB
R Gregory Brophy
Chief Executive Officer and director
TR
Tracy Ryan
Executive officer and director
TB
Timothy Brahm
Director
DR
Diederik van der Reijt
Director